Invst, LLC Bristol Myers Squibb CO Transaction History

Invst, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 24, 2024	BUY	$47.98 - $54.4 $1,679 - $1,904	35 Added 0.75%	4,680 $253,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $18,567 - $22,156	-383 Reduced 7.62%	4,645 $238,000
Q3 2023 Nov 21, 2023	BUY	$57.89 - $64.73 $10,941 - $12,233	189 Added 3.91%	5,028 $291,000
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $18,412 - $20,443	289 Added 6.35%	4,839 $309,000
Q1 2023 Apr 28, 2023	BUY	$65.71 - $74.53 $7,753 - $8,794	118 Added 2.66%	4,550 $315,000
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $753 - $891	-11 Reduced 0.25%	4,432 $318,000
Q3 2022 Nov 23, 2022	SELL	$0.13 - $76.84 $20 - $11,910	-155 Reduced 3.37%	4,443 $304,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $1,670 - $1,839	-23 Reduced 0.5%	4,598 $344,000
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $33,260 - $39,882	541 Added 13.26%	4,621 $352,000
Q4 2021 Feb 25, 2022	SELL	$53.63 - $62.52 $527,343 - $614,759	-9,833 Reduced 70.67%	4,080 $277,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $4,023 - $4,713	-68 Reduced 0.49%	13,913 $823,000
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $2,662 - $2,899	43 Added 0.31%	13,981 $941,000
Q1 2021 Jun 23, 2021	SELL	$59.34 - $66.74 $712 - $800	-12 Reduced 0.09%	13,938 $870,000
Q4 2020 Jun 23, 2021	SELL	$57.74 - $65.43 $692 - $785	-12 Reduced 0.09%	13,950 $865,000
Q3 2020 Jun 23, 2021	BUY	$57.43 - $63.64 $582,971 - $646,009	10,151 Added 266.36%	13,962 $835,000
Q2 2020 Jun 23, 2021	BUY	$54.82 - $64.09 $208,919 - $244,246	3,811 New	3,811 $226,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

Stay updated on Invst, LLC with notifications on news.